Nadeem et al. found that the ITK inhibitor significantly inhibits Th17/Th2 and neutrophilic/eosinophilic airway inflammation in asthmatic mice and concluded that the ITK inhibitor could be used as an alternative therapeutic option for corticosteroid-refractory asthma [52]. Here, ITK is linked to asthma.